Compare PSBD & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PSBD | PEPG |
|---|---|---|
| Founded | 2009 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 385.0M | 317.6M |
| IPO Year | 2024 | 2022 |
| Metric | PSBD | PEPG |
|---|---|---|
| Price | $12.26 | $5.36 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $13.30 | $9.50 |
| AVG Volume (30 Days) | 78.1K | ★ 824.2K |
| Earning Date | 11-05-2025 | 11-12-2025 |
| Dividend Yield | ★ 13.99% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.51 | $0.88 |
| 52 Week High | $16.16 | $6.72 |
| Indicator | PSBD | PEPG |
|---|---|---|
| Relative Strength Index (RSI) | 51.63 | 51.50 |
| Support Level | $12.10 | $5.04 |
| Resistance Level | $12.45 | $6.72 |
| Average True Range (ATR) | 0.23 | 0.58 |
| MACD | 0.05 | -0.06 |
| Stochastic Oscillator | 75.36 | 30.02 |
Palmer Square Capital BDC Inc is a financial services company that lends to and invests in corporate debt securities of companies, including small to large private U.S. companies. Their investment objective is to maximize total return, comprised of current income and capital appreciation.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.